One previous study showed that SNAP-25 was elevated in the CSF of patients with mild cognitive impairment (MCI) and AD, indicating that SNAP-25 may be a useful biomarker reflecting synapse degeneration (Brinkmalm et al., 2014; Zhang et al., 2018). This evidence concerns the gene SNAP25 and Cognitive impairment.